Martha Morrell - 03 Mar 2022 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role: Chief Medical Officer
Signature: /s/ Irina Ridley, Attorney-In-Fact
Issuer symbol: NPCE
Transactions as of: 03 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2022, 19:06:03 UTC
Previous filing: 29 Jun 2021
Next filing: 11 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NPCE	Common Stock	Award	$0	+46,760	+476%	$0.000000	56,588	03 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NPCE	Stock Option (Right to Buy)	Award	$0	+93,530		$0.000000	93,530	03 Mar 2022	Common Stock	93,530	$8.15	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
F2	25% of the shares subject to the option vest on March 3, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable.